Search
for

    Sort by

    Research 121–150 of 1000+

    1. Repurposing of Various Current Medicines as Radioprotective Agents Anti-cancer agents in medicinal chemistry · 2022
    2. BI39 Oncological therapies and hair disorders: a narrative approach on permanent chemotherapy-induced alopecia. A literature review of cancer-related therapies and their associated hair and scalp disorders British Journal of Dermatology · 2024
    3. Onychomatricoma with classic features: Case report and review of the literature Journal of The American Academy of Dermatology · 2013
    4. Loose anchoring of anagen hairs and pili torti due to erlotinib International Journal of Trichology · 2016 · 5 citations
    5. Persistent hair growth during treatment with the EGFR inhibitor erlotinib Dermatology Online Journal · 2009 · 39 citations
    6. Cutaneous toxicities of cancer therapy 2002 · 114 citations
    7. Male alopecia, finasteride, and cancer risk Community oncology · 2012
    8. The Dark Side of Gefitinib: Reflectance Confocal Microscopy Applied to Hair Hyperpigmentation Skin Appendage Disorders · 2019 · 4 citations
    9. Male pattern hair loss InnovAiT Education and inspiration for general practice · 2025
    10. The management of EGFR inhibitor adverse events: a case series and treatment paradigm International Journal of Dermatology · 2012 · 32 citations
    11. Toxic Effect of Platinum Compounds: Molecular Mechanisms of Toxicity ˜Al-œRafidain journal of medical sciences. · 2021 · 1 citations
    12. Radiotherapy-Induced Skin Fibrosis: Pathophysiology, Emerging Therapeutics, and the Role of Dermatology American Journal of Clinical Dermatology · 2026
    13. Vitamin D3 and chemotherapy-induced alopecia Nutrition · 1996 · 11 citations
    14. DERMATOLOGICAL ADVERSE EFFECTS OF CHEMOTHERAPEUTIC AGENTS: EXPERIENCE FROM A TERTIARY CENTRE Journal of evolution of medical and dental sciences · 2017
    15. Cancer Chemotherapy: an Introduction 1989 · 4 citations
    16. Cancer Chemotherapy: A Review Update of the Mechanisms of Actions, Prospects, and Associated Problems BIOMED natural and applied science · 2021
    17. Possible Therapeutic Effects of Ozone Mixture on Hypoxia in Tumor Development 2017 · 25 citations
    18. Chemical and green synthesis of nanoparticles and their efficacy on cancer cells Elsevier eBooks · 2019 · 21 citations
    19. Management of Colorectal Cancer Using Nanocarriers-based Drug Delivery for Herbal Bioactives: Current and Emerging Approaches Current Pharmaceutical Biotechnology · 2023 · 2 citations
    20. Editorial: Androgen-dependent diseases and their treatment Frontiers in Endocrinology · 2024
    21. Drug repurposing: A novel strategy to target cancer stem cells and therapeutic resistance Genes & Diseases · 2023 · 56 citations
    22. Abnormal hair growth in patients (pts) with metastatic colorectal cancer (mCRC) treated with the anti-epidermal growth factor receptor (EGFr) monoclonal antibody (mAb) panitumumab (Pmab) Journal of Clinical Oncology · 2008 · 3 citations
    23. Aesthetic medicine treatments for oncology patients — a narrative literature review Nowotwory Journal of Oncology · 2026
    24. Cyproterone Acetate in the Treatment of Sexual Disorders: Pharmacological Base and Clinical Experience Experimental and clinical endocrinology & diabetes · 2009 · 30 citations
    25. Treatment of Epidermal Growth Factor Receptor Inhibitor-Induced Acneiform Eruption with Topical Recombinant Human Epidermal Growth Factor Dermatology · 2012 · 19 citations
    26. Efficacy and Safety of Cinobufacin Combined with Chemotherapy for Advanced Breast Cancer: A Systematic Review and Meta‐Analysis Evidence-based Complementary and Alternative Medicine · 2020 · 8 citations
    27. Safety of Tyrosine Kinase Inhibitors in Patients With Differentiated Thyroid Cancer: Real-World Use of Lenvatinib and Sorafenib in Korea Frontiers in Endocrinology · 2019 · 39 citations
    28. Advances in clinical applications of microneedle Frontiers in Pharmacology · 2025 · 9 citations
    29. Inhaled Medicines for Targeting Non-Small Cell Lung Cancer Pharmaceutics · 2023 · 2 citations
    30. Open-Label, Randomized, Multicenter, Phase III Study Comparing Oral Paclitaxel Plus Encequidar Versus Intravenous Paclitaxel in Patients With Metastatic Breast Cancer Journal of Clinical Oncology · 2022 · 9 citations